HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development and Application of a Risk Prediction Model for In-Hospital Stroke After Transcatheter Aortic Valve Replacement: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.

AbstractBACKGROUND:
Stroke is a serious complication after transcatheter aortic valve replacement (TAVR), yet predictive models are not available. A new risk model for in-hospital stroke after TAVR was developed and used to estimate site-specific performance.
METHODS:
We included 97,600 TAVR procedures from 521 sites in The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry from July 2014 to June 2017. Association between baseline covariates and in-hospital stroke was estimated by logistic regression. Discrimination was evaluated by C-statistic. Calibration was tested internally via cross-validation. Hierarchical modeling was used to estimate risk-adjusted site-specific performance.
RESULTS:
Median age was 82 years, 44,926 (46.0%) were women, and 1,839 (1.9%) had in-hospital stroke. Covariates associated with stroke (odds ratio) included transapical access (1.44), access excluding transapical and transfemoral (1.77), prior stroke (1.57), prior transient ischemic attack (1.50), preprocedural shock, inotropes or mechanical assist device (1.48), smoking (1.28), porcelain aorta (1.23), peripheral arterial disease (1.21), age per 5 years (1.11), glomerular filtration rate per 5 mL/min (0.97), body surface area per m2 (0.55 male; 0.43 female), and prior aortic valve (0.78) and nonaortic valvular (0.42) procedures. The C-statistic was 0.622. Calibration curves demonstrated agreement between observed and expected stroke rates. Hierarchical modeling showed 10 (1.9%) centers with significantly higher odds ratios for in-hospital stroke than their peers.
CONCLUSIONS:
A risk model for in-hospital stroke after TAVR was developed from The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry and used to estimate site-specific stroke performance. This model can serve as a valuable resource for quality improvement, clinical decision making, and patient counseling.
AuthorsVinod H Thourani, Sean M O'Brien, John J Kelly, David J Cohen, Eric D Peterson, Michael J Mack, David M Shahian, Frederick L Grover, John D Carroll, J Matthew Brennan, Jessica Forcillo, Suzanne V Arnold, Sreekanth Vemulapalli, Susan Fitzgerald, David R Holmes, Joseph E Bavaria, Fred H Edwards
JournalThe Annals of thoracic surgery (Ann Thorac Surg) Vol. 107 Issue 4 Pg. 1097-1103 (04 2019) ISSN: 1552-6259 [Electronic] Netherlands
PMID30529671 (Publication Type: Journal Article, Multicenter Study)
CopyrightCopyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Topics
  • Aged
  • Aged, 80 and over
  • Aortic Valve Stenosis (diagnostic imaging, surgery)
  • Female
  • Hospital Mortality
  • Humans
  • Male
  • Predictive Value of Tests
  • Prevalence
  • Registries
  • Reproducibility of Results
  • Risk Assessment
  • Risk Management
  • Societies, Medical
  • Stroke (epidemiology, etiology)
  • Thoracic Surgery
  • Transcatheter Aortic Valve Replacement (adverse effects, methods, mortality)
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: